A Phase II Trial Comparing Z-102 With Placebo In Patients With Moderate To Severe Rheumatoid Arthritis
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
Thus study will test an experimental drug called Z-102 (combination of prednisolone and
dipyridamole) to treat patients with moderate to severe rheumatoid arthritis.